Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 5 | EJNMMI Radiopharmacy and Chemistry

Fig. 5

From: Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

Fig. 5

[18F]JNJ42259152 BPND values after 5 days treatment with SCH23390. Left: Transversal images of PDE10A binding in the brain. Images are overlaid on a VOI map and presented as averaged, parametric BPND images (Logan Reference) at baseline conditions (a), at day 5 (b) and day 15 (c) of the experiment. Right: Averaged (d) and individual (e) BPND values in striatum of SCH23390 treated rats at baseline conditions, after 5 days of amphetamine treatment (day 5) and after 10 days of washout (day 15). Each line represents a repeated measurement in a single rat at different stages of treatment. Wilcoxon matched pair test; *p < 0.05, **p < 0.005

Back to article page